Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics (PRQR) Short-term Investments (2021 - 2023)

Historic Short-term Investments for ProQR Therapeutics (PRQR) over the last 3 years, with Q3 2023 value amounting to $277590.6.

  • ProQR Therapeutics' Short-term Investments rose 9118.92% to $277590.6 in Q3 2023 from the same period last year, while for Sep 2023 it was $277590.6, marking a year-over-year increase of 9118.92%. This contributed to the annual value of $1.3 million for FY2022, which is 7274.4% down from last year.
  • ProQR Therapeutics' Short-term Investments amounted to $277590.6 in Q3 2023, which was up 9118.92% from $405079.8 recorded in Q2 2023.
  • In the past 5 years, ProQR Therapeutics' Short-term Investments ranged from a high of $4.6 million in Q4 2021 and a low of $1934.8 during Q1 2021
  • For the 3-year period, ProQR Therapeutics' Short-term Investments averaged around $1.1 million, with its median value being $405079.8 (2023).
  • The largest annual percentage gain for ProQR Therapeutics' Short-term Investments in the last 5 years was 1608419.39% (2022), contrasted with its biggest fall of 9455.95% (2022).
  • Over the past 3 years, ProQR Therapeutics' Short-term Investments (Quarter) stood at $4.6 million in 2021, then crashed by 71.8% to $1.3 million in 2022, then crashed by 78.46% to $277590.6 in 2023.
  • Its last three reported values are $277590.6 in Q3 2023, $405079.8 for Q2 2023, and $636491.7 during Q1 2023.